Untargeted profiling
Broad molecular surveys to identify metabolic features associated with clinically defined states.
Molecular layer
Metabolomics
Metabolic signatures interpreted in the context of phenotype, treatment and inflammatory biology.
Metabolic phenotyping
Map the metabolic state of disease.
Metabolomics captures biochemical changes that emerge from disease, treatment, organ function and the surrounding microenvironment. We use targeted and discovery-driven approaches to identify signatures worth testing rather than treating feature lists as conclusions.
Targeted analysis
Focused measurement of pathways and metabolites selected from biological hypotheses or discovery data.
Clinically relevant matrices
Plasma and other patient-derived biospecimens chosen around the biological process of interest.
From pattern to biomarker
Prioritizing reproducible features that remain interpretable in the context of clinical phenotype.